BNP Paribas Financial Markets
CRVO icon

BNP Paribas Financial Markets’s CervoMed CRVO Stock Holding History

BNP Paribas Financial Markets’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282 Hold
91
– – ﹤0.01% 5734
2026
Q1 		$359 Hold
91
– – ﹤0.01% 5570
2025
Q4 		$719 Hold
91
– – ﹤0.01% 5439
2025
Q3 		$736 Sell
91
-4
-4% -$34 ﹤0.01% 5267
2025
Q2 		$597 Sell
95
-189
-67% -$1.61K ﹤0.01% 5207
2025
Q1 		$2.6K Sell
284
-13,489
-98% -$51.4K ﹤0.01% 4948
2024
Q4 		$32.2K Buy
+13,773
New +$134K ﹤0.01% 4582

Other funds holding CRVO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
SAI
Savvy Advisors Inc New York $4.71B AUM 25.36% 1-Year Est. Return

BNP Paribas Financial Markets's CRVO Position: Q2 2026 in Review

BNP Paribas Financial Markets held its CervoMed (CRVO) position steady in Q2 2026 at 91 shares worth $282. The position accounts for ﹤0.01% of the portfolio, ranked #5734.

BNP Paribas Financial Markets first reported a position in CRVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $32.2K in Q4 2024. 32 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

  • BNP Paribas Financial Markets held 91 shares of CervoMed worth $282 as of Q2 2026.
  • BNP Paribas Financial Markets left its CervoMed share count unchanged in Q2 2026.
  • CervoMed made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5734 holding.
  • BNP Paribas Financial Markets first reported a position in CervoMed in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's CervoMed position peaked at $32.2K in Q4 2024.
  • 32 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.